HSA issues Class 2 retail-level recall of seven BD

Cresthaven AnalyticsIntelligence Brief

Headline

HSA issues Class 2 retail-level recall of seven BD ChloraPrepTM 1 mL Applicator batches over sterility packaging concern

Executive Summary

The Health Sciences Authority (HSA) of Singapore issued a Class 2 retail-level recall on 17 July 2026 covering seven batches of BD ChloraPrepTM 1 mL Applicator, Clear. BD Holdings Pte Ltd initiated the recall citing a potential breach of sterility in the packaging. Under HSA's framework, Class 2 applies to recalls of products with issues that would not likely cause serious adverse health outcomes.

Bottom Line

HSA's 17 July 2026 notice identifies seven batches of BD ChloraPrepTM 1 mL Applicator, Clear as subject to a Class 2 retail-level recall for a potential sterility packaging breach. Cresthaven reading: supply-chain holders in Singapore's healthcare sector with any of the seven named batches in inventory face a stock-return request from the local company.

Key Regulatory Signals

Seven Specific Batches Affected: The recall covers batch numbers 6031034, 4221945, 4250729, 5124984, 5157968, 5199118, and 5211907 of BD ChloraPrepTM 1 mL Applicator, Clear, containing 2% w/v chlorhexidine gluconate and 70% v/v isopropyl alcohol. Cresthaven reading: hospitals, clinics, and pharmacies holding any of these seven batches are the direct operational focus of the recall instructions.
Retail-Level Scope: HSA has designated this a retail-level recall, meaning the affected batches are to be withdrawn from retail suppliers, hospitals, clinics, pharmacies, and wholesale suppliers. The recall does not extend to patient or consumer-level retrieval under HSA's recall-level framework.
Class 2 Classification: HSA classifies this recall as Class 2, which under its framework applies to products with issues that would not likely cause serious adverse health outcomes. HSA states that not all recalls lead to press releases and that it issues a press release when a recall involves a widely distributed product or one posing a serious health risk.
Recall Instructions to Supply-Chain Holders: HSA's recall notice states that hospitals, clinics, and pharmacies should stop supplying the affected batches and return remaining stocks to BD Holdings Pte Ltd. The notice does not state a deadline for completion of the return.

Regulatory Delta

This recall follows HSA's established Class 2 retail-level recall framework. It represents procedural continuity with prior product-quality actions, not an escalation in regulatory posture. - The sterility packaging concern is the specific new element. HSA's notice states the issue does not necessarily imply the product is unsafe or inefficacious. - No cross-agency coordination or adjacent regulatory action from a peer jurisdiction is identified in the source for this recall.

Materiality Classification

LOW — A Class 2 retail-level recall of specific product batches affecting named supply-chain holders; HSA's own classification indicates the issue would not likely cause serious adverse health outcomes, and no sector-wide compliance obligation or enforcement sweep is indicated.

Intelligence Outlook

Monitor HSA for any reclassification of this recall to Class 1 or any expansion of the recall level to consumer level if further investigation identifies a broader safety concern.